{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:31:35Z","timestamp":1790314295655,"version":"4.1.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejpb.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:34:10Z","timestamp":1556883250000},"page":"121-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Expanding the applications of microneedles in dermatology"],"prefix":"10.1016","volume":"140","author":[{"given":"Akmal H.","family":"Sabri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuriah","family":"Abdulhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volha","family":"Shpadaruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Scurr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.05.001_b0005","unstructured":"M.E. Aulton, Aulton\u2019s Pharmaceutics The design and manufacture of medicines, third, churchill livingstone, China, 2011."},{"key":"10.1016\/j.ejpb.2019.05.001_b0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00249-007-0191-x","article-title":"Follow-up of drug permeation through excised human skin with confocal Raman microspectroscopy","volume":"36","author":"Tfayli","year":"2007","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.ejpb.2019.05.001_b0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1359-6446(04)03180-0","article-title":"The transdermal revolution","volume":"9","author":"Thomas","year":"2004","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.ejpb.2019.05.001_b0020","first-page":"1305","article-title":"The principles of percutaneous absorption","volume":"28","author":"Rothman","year":"1943","journal-title":"Transl. Res."},{"issue":"11","key":"10.1016\/j.ejpb.2019.05.001_b0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2004.03.002","article-title":"Skin deep","volume":"58","author":"Hadgraft","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/js990154g","article-title":"Transdermal penetration enhancers: Applications, limitations, and potential","volume":"88","author":"Finnin","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0250-474X.40340","article-title":"Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery","volume":"70","author":"Chandrashekar","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2014.05.022","article-title":"Transdermal drug delivery: 30 + years of war and still fighting!","volume":"190","author":"Wiedersberg","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0050","first-page":"406","article-title":"Global skin disease morbidity and mortality an update from the global burden of disease study 2013","volume":"44113","author":"Silverberg","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"2013","key":"10.1016\/j.ejpb.2019.05.001_b0055","first-page":"1527","article-title":"The global burden of skin disease an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0060","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2014.530","article-title":"The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries","volume":"135","author":"Dalgard","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0065","unstructured":"J. Schofield, D. Grindlay, H.C. Williams, Skin healthcare needs assessment, First, Centre of Evidence Based Dermatology, University of Nottingham, 2009. papers2:\/\/publication\/uuid\/018AEA8D-585A-44C9-BE76-A24921CDD08C."},{"key":"10.1016\/j.ejpb.2019.05.001_b0070","series-title":"Maxillofac. Surg., Third Edit","first-page":"714","article-title":"Skin Cancer of the Head and Neck","author":"Singh","year":"2017"},{"key":"10.1016\/j.ejpb.2019.05.001_b0075","doi-asserted-by":"crossref","unstructured":"S. Kaushik, A.H. Hord, D.D. Denson, D. V Mcallister, S. Smitra, M.G. Allen, M.R. Prausnitz, Lack of pain associated with microfabricated microneedles (2001) 2000\u20132002.","DOI":"10.1213\/00000539-200102000-00041"},{"key":"10.1016\/j.ejpb.2019.05.001_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11095-010-0101-2","article-title":"Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public","volume":"28","author":"Birchall","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4155\/tde.15.61","article-title":"Chemical penetration enhancers","volume":"6","author":"Lopes","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2019.05.001_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.05.001_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1258\/095646204322637182","article-title":"The global burden of disease attributable to contaminated injections given in health care settings","volume":"15","author":"Hauri","year":"2004","journal-title":"Int. J. STD AIDS."},{"key":"10.1016\/j.ejpb.2019.05.001_b0100","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/0091270010378859","article-title":"Microneedles: a valuable physical enhancer to increase transdermal drug delivery","author":"Escobar-Ch\u00e1vez","year":"2011","journal-title":"J. Clin. Pharmacol. 51"},{"key":"10.1016\/j.ejpb.2019.05.001_b0105","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/jp.2016.30","article-title":"Vitamin K prophylaxis for prevention of vitamin K de fi ciency bleeding: a systematic review","volume":"36","author":"Sankar","year":"2016","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2007.01.014","article-title":"The determination of the mechanical strength of tablets of different shapes","volume":"67","author":"Davies","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaad.2015.09.024","article-title":"Microneedling in skin of color: A review of uses and efficacy","volume":"74","author":"Cohen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2017.02.011","article-title":"Microneedle, bio-microneedle and bio-inspired microneedle: A review","volume":"251","author":"Ma","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0125","unstructured":"V.A.P. Martin S. Gerstel, United States Paten, Patentimages.Storage.Googleapis. \u2026. (1972) 1\u20134. https:\/\/patentimages.storage.googleapis.com\/pdfs\/US2283688.pdf."},{"key":"10.1016\/j.ejpb.2019.05.001_b0130","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.05.001_b0135","first-page":"766","article-title":"Genetic transformation of nematodes using arrays of micromechanical piercing structures","volume":"19","author":"Hashmi","year":"1995","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejpb.2019.05.001_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/js980042+","article-title":"Microfabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Henry","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.05.001_b0150","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1586\/erv.10.134","article-title":"Intanza\u00ae: a new intradermal vaccine for seasonal influenza","volume":"9","author":"Atmar","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ejpb.2019.05.001_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/hv.8.1.18419","article-title":"Current evidence on intradermal influenza vaccines administered by SoluviaTM licensed micro injection system","volume":"8","author":"Icardi","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ejpb.2019.05.001_b0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/14712598.2011.557658","article-title":"Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement","volume":"11","author":"Ansaldi","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejpb.2019.05.001_b0165","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1586\/erv.10.117","article-title":"Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine","volume":"9","author":"Sullivan","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ejpb.2019.05.001_b0170","doi-asserted-by":"crossref","unstructured":"N.L. Bragazzi, A. Orsi, F. Ansaldi, R. Gasparini, G. Icardi, Fluzone\u00ae intra-dermal (Intanza\u00ae\/Istivac\u00ae Intra-dermal): An updated overview (2016). http:\/\/doi.org\/10.1080\/21645515.2016.1187343.","DOI":"10.1080\/21645515.2016.1187343"},{"key":"10.1016\/j.ejpb.2019.05.001_b0175","first-page":"7","article-title":"The intradermal vaccination: past experiences and current perspectives","volume":"51","author":"Sticchi","year":"2010","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.ejpb.2019.05.001_b0180","first-page":"21","article-title":"A qualitative assessment of the views of children and parents of premature babies on microneedle-mediated monitoring as a potential alternative to blood sampling","volume":"20","author":"Mooney","year":"2012","journal-title":"Int. J. Pharm. Pr."},{"key":"10.1016\/j.ejpb.2019.05.001_b0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/ijpp.12081","article-title":"Children\u2019s views on microneedle use as an alternative to blood sampling for patient monitoring","volume":"22","author":"Mooney","year":"2014","journal-title":"Int. J. Pharm. Pract."},{"key":"10.1016\/j.ejpb.2019.05.001_b0190","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.vaccine.2015.12.002","article-title":"Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use","volume":"34","author":"Marshall","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.05.001_b0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4269\/ajtmh.2003.68.341","article-title":"Fear of injections in young adults: Prevalence and associations","volume":"68","author":"Nir","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2019.05.001_b0200","first-page":"169","article-title":"Needle phobia: a neglected diagnosis","volume":"41","author":"Hamilton","year":"1995","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.ejpb.2019.05.001_b0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10544-008-9208-1","article-title":"Clinical administration of microneedles: Skin puncture, pain and sensation","volume":"11","author":"Haq","year":"2009","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.ejpb.2019.05.001_b0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm0402-415","article-title":"Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery","volume":"8","author":"Mikszta","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2019.05.001_b0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biomaterials.2015.04.007","article-title":"Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch","volume":"57","author":"Hirobe","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.05.001_b0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AJP.0b013e318225dbe9","article-title":"Rapid local anesthesia in humans using minimally invasive microneedles","volume":"28","author":"Gupta","year":"2012","journal-title":"Clin. J. Pain."},{"key":"10.1016\/j.ejpb.2019.05.001_b0225","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1073\/pnas.0710355105","article-title":"Microneedles permit transdermal delivery of a skin-impermeant medication to humans","volume":"105","author":"Wermeling","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: An emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.01.024","article-title":"Super-short solid silicon microneedles for transdermal drug delivery applications","volume":"389","author":"Wei-Ze","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1013607400040","article-title":"Macroflux\u00ae microprojection array patch technology: A new and efficient approach for intracutaneous immunization","volume":"19","author":"Matriano","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11095-010-0177-8","article-title":"Rapid intradermal delivery of liquid formulations using a hollow microstructured array","volume":"28","author":"Burton","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0250","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2019.05.001_b0255","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/smll.201503093","article-title":"Microneedles for the noninvasive structural and functional assessment of dermal lymphatic vessels","volume":"12","author":"Brambilla","year":"2016","journal-title":"Small."},{"key":"10.1016\/j.ejpb.2019.05.001_b0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0041-3879(81)90032-5","article-title":"The Mantoux test in tuberculosis: correlations between the diameters of the dermal responses and the serum protein levels","volume":"62","author":"Kardjito","year":"1981","journal-title":"Tubercle"},{"key":"10.1016\/j.ejpb.2019.05.001_b0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.provac.2012.04.017","article-title":"Clinical performance and safety of the ID adapter, a prototype intradermal delivery technology for vaccines, drugs, and diagnostic tests","volume":"6","author":"Jarrahian","year":"2012","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/adhm.201300185","article-title":"Chitin microneedles for an easy-to-use tuberculosis skin test","volume":"3","author":"Jin","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2019.05.001_b0275","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajim.20230","article-title":"Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers","volume":"490","author":"Pruss-Ustun","year":"2005","journal-title":"Am. J. Indus. Med."},{"key":"10.1016\/j.ejpb.2019.05.001_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mic.2002.119928","article-title":"Estimation of the risk of bloodborne pathogens to health care workers after a needlestick injury in Taiwan","volume":"30","author":"Shiao","year":"2002","journal-title":"Am. J. Infect. Control."},{"issue":"2011","key":"10.1016\/j.ejpb.2019.05.001_b0285","first-page":"465","article-title":"Needlestick injuries and infectious patients in a major academic medical centre from to 2010","volume":"69","author":"Frijstein","year":"2003","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.ejpb.2019.05.001_b0290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2010.10.033","article-title":"Separable arrowhead microneedles","volume":"149","author":"Chu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"McCrudden","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2015.10.002","article-title":"IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery","volume":"218","author":"M\u00f6nk\u00e4re","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11095-010-0097-7","article-title":"Two-layered dissolving microneedles for percutaneous delivery of peptide\/protein drugs in rats","volume":"28","author":"Fukushima","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2013.04.023","article-title":"Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration","volume":"86","author":"McGrath","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13346-016-0282-2","article-title":"Long-term stability of influenza vaccine in a dissolving microneedle patch","volume":"7","author":"Mistilis","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2012.12.002","article-title":"Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles","volume":"166","author":"Choi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0325","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.biomaterials.2011.01.014","article-title":"Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose","volume":"32","author":"Lee","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.05.001_b0330","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11095-012-0674-z","article-title":"Erythropoietin-coated ZP-microneedle transdermal system: Preclinical formulation, stability, and delivery","volume":"29","author":"Peters","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11095-010-0192-9","article-title":"Parathyroid hormone (1\u201334)-coated microneedle patch system: Clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis","volume":"28","author":"Daddona","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0340","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11095-011-0419-4","article-title":"Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery","volume":"28","author":"Migalska","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0345","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jconrel.2012.05.030","article-title":"The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin","volume":"161","author":"Liu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0350","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1016\/j.actbio.2013.06.029","article-title":"Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats","volume":"9","author":"Ling","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2019.05.001_b0355","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0168-3659(04)00171-3","article-title":"Transdermal delivery of desmopressin using a coated microneedle array patch system","volume":"97","author":"Cormier","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0360","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11095-011-0524-4","article-title":"Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action","volume":"29","author":"Zhang","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0365","doi-asserted-by":"crossref","DOI":"10.1080\/14737167.2018.1485100","article-title":"Therapeutic applications and pharmacoeconomics of microneedle technology","author":"Richter-Johnson","year":"2018","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0370","first-page":"2513","article-title":"Microneedle arrays allow lower microbial penetration than hypodermic needles","volume":"26","author":"Donnelly","year":"2009","journal-title":"In Vitro"},{"key":"10.1016\/j.ejpb.2019.05.001_b0375","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrmicro2619","article-title":"The skin microbiome","volume":"9","author":"Grice","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0380","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejpb.2017.04.029","article-title":"Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo","volume":"117","author":"Vicente-Perez","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0390","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/43088","article-title":"A peptide antibiotic from human skin","volume":"387","author":"Harder","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2019.05.001_b0395","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-1119(98)00480-6","article-title":"Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation","volume":"222","author":"Liu","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.ejpb.2019.05.001_b0400","doi-asserted-by":"crossref","unstructured":"J. Park, M.G. Allen, M.R. Prausnitz, Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery, 104 (2005) 51\u201366. http:\/\/doi.org\/10.1016\/j.jconrel.2005.02.002.","DOI":"10.1016\/j.jconrel.2005.02.002"},{"key":"10.1016\/j.ejpb.2019.05.001_b0405","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nbt.2316","article-title":"Combinatorial discovery of polymers resistant to bacterial attachment","volume":"30","author":"Hook","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0410","unstructured":"A. Hou, B. Cohen, A. Haimovic, N. Elbuluk, Microneedling, Dermatologic Surg. (2016) 1. 10.1097\/DSS.0000000000000924."},{"key":"10.1016\/j.ejpb.2019.05.001_b0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","article-title":"Effect of microneedle design on pain in human volunteers","volume":"24","author":"Gill","year":"2008","journal-title":"Clin J Pain."},{"key":"10.1016\/j.ejpb.2019.05.001_b0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2008.06.016","article-title":"In vivo assessment of safety of microneedle arrays in human skin","volume":"35","author":"Bal","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0425","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1002\/jps.22083","article-title":"Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs","volume":"99","author":"Banks","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0430","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2019.05.001_b0435","unstructured":"Search - Zosano Pharma, (n.d.). http:\/\/ir.zosanopharma.com\/search.cfm?ndq_keyword=thyroid&SearchYear= (accessed August 21, 2017)."},{"key":"10.1016\/j.ejpb.2019.05.001_b0440","unstructured":"MicroCor \u2013 Corium Inc., (n.d.). http:\/\/www.coriumintl.com\/home\/technology\/microcor\/ (accessed August 21, 2017)."},{"key":"10.1016\/j.ejpb.2019.05.001_b0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamadermatol.2013.6955","article-title":"Facial allergic granulomatous reaction and systemic hypersensitivity associated with microneedle therapy for skin rejuvenation","volume":"150","author":"Soltani-Arabshahi","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0450","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lapl.200910134","article-title":"In vivo visualization of microneedle conduits in human skin using laser scanning microscopy","volume":"7","author":"Bal","year":"2010","journal-title":"Laser Phys. Lett."},{"key":"10.1016\/j.ejpb.2019.05.001_b0455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2011.05.021","article-title":"Kinetics of skin resealing after insertion of microneedles in human subjects","volume":"154","author":"Gupta","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0460","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11095-010-0122-x","article-title":"Formation and closure of microchannels in skin following microporation","volume":"28","author":"Kalluri","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0465","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2012.08.015","article-title":"Diclofenac delays micropore closure following microneedle treatment in human subjects","volume":"163","author":"Brogden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0470","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jps.23844","article-title":"Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin","volume":"103","author":"Ghosh","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0475","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.ejpb.2019.05.001_b0480","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2015.11.038","article-title":"A facile system to evaluate in vitro drug release from dissolving microneedle arrays","volume":"497","author":"Larra\u00f1eta","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0485","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10544-005-3024-7","article-title":"Sugar micro needles as transdermic drug delivery system","volume":"7","author":"Miyano","year":"2005","journal-title":"Biomed. Microdevices."},{"key":"10.1016\/j.ejpb.2019.05.001_b0490","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2014.11.023","article-title":"European Journal of Pharmaceutics and Biopharmaceutics Structural characterisation and transdermal delivery studies on sugar microneedles : Experimental and finite element modelling analyses","volume":"89","author":"Loizidou","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0495","doi-asserted-by":"crossref","DOI":"10.1039\/C3TB21698E","article-title":"Improved polyvinylpyrrolidone microneedle arrays with non-stoichiometric cyclodextrin","volume":"2","author":"Chen","year":"2014","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.ejpb.2019.05.001_b0500","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejpb.2013.10.001","article-title":"Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin","volume":"86","author":"Liu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0505","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11095-007-9286-4","article-title":"Coating formulations for microneedles","volume":"24","author":"Gill","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0510","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jbiomech.2003.12.010","article-title":"Insertion of microneedles into skin : measurement and prediction of insertion force and needle fracture force","volume":"37","author":"Davis","year":"2004","journal-title":"J. Biomech."},{"key":"10.1016\/j.ejpb.2019.05.001_b0515","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/erd.11.20","article-title":"Microneedle arrays as medical devices for enhanced transdermal drug delivery","volume":"8","author":"Garland","year":"2011","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.ejpb.2019.05.001_b0520","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2013.04.045","article-title":"Hydrogel-forming microneedle arrays exhibit antimicrobial properties: Potential for enhanced patient safety","volume":"451","author":"Donnelly","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0525","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/php.12209","article-title":"Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors","volume":"90","author":"Donnelly","year":"2014","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/138920009787846350","article-title":"Cutaneous metabolism in transdermal drug delivery","volume":"10","author":"Zhang","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2019.05.001_b0535","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11095-013-1137-x","article-title":"Dissolvable microneedle arrays for intradermal delivery of biologics: Fabrication and application","volume":"31","author":"Bediz","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0540","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1002\/cncr.27566","article-title":"Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening","volume":"118","author":"Katalinic","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2019.05.001_b0545","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2019.05.001_b0550","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jaad.2006.08.039","article-title":"Basal cell carcinoma on the trunk is associated with excessive sun exposure","volume":"56","author":"Neale","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0555","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindel\u00f6f","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0560","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2015.02.004","article-title":"Beta genus papillomaviruses and skin cancer","volume":"479\u2013480","author":"Howley","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2019.05.001_b0565","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/sj.jid.5700934","article-title":"Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study","volume":"127","author":"Karagas","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0570","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/sj.bjc.6602475","article-title":"Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden","volume":"92","author":"Odenbro","year":"2005","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.ejpb.2019.05.001_b0575","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jaad.2010.01.040","article-title":"Skin cancer education and early detection at the beach: A randomized trial of dermatologist examination and biometric feedback","volume":"64","author":"Emmons","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaad.2016.07.045","article-title":"Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review","volume":"76","author":"Brunssen","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0585","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","article-title":"The epidemiology of UV induced skin cancer","volume":"63","author":"Armstrong","year":"2001","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0590","doi-asserted-by":"crossref","first-page":"650258","DOI":"10.1155\/2011\/650258","article-title":"Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease","volume":"2011","author":"G\u00f6ppner","year":"2011","journal-title":"J Skin Cancer."},{"key":"10.1016\/j.ejpb.2019.05.001_b0595","first-page":"506","article-title":"Basal cell and squamous cell skin cancers","volume":"94","author":"Miller","year":"2002","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"10.1016\/j.ejpb.2019.05.001_b0600","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/02652048.2011.559287","article-title":"A novel microparticulate vaccine for melanoma cancer using transdermal delivery","volume":"28","author":"Bhowmik","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2019.05.001_b0605","series-title":"Maxillofac. Surg., Third Edit","first-page":"761","article-title":"Nonsurgical management of non-melanoma skin cancer","author":"Coyle","year":"2017"},{"key":"10.1016\/j.ejpb.2019.05.001_b0610","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1523-1747.2002.01807.x","article-title":"Discriminating basal cell carcinoma from its surrounding tissue by raman spectroscopy","volume":"119","author":"Nijssen","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0615","series-title":"Cutaneous Lesions of the Periorbital and Lid Region","author":"Wiltfang","year":"2017"},{"key":"10.1016\/j.ejpb.2019.05.001_b0620","first-page":"1369","article-title":"Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease","volume":"12","author":"Goldenberg","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0625","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/571734","article-title":"Nonsurgical treatment options for Basal cell carcinoma","volume":"2011","author":"Lien","year":"2011","journal-title":"J. Skin Cancer."},{"key":"10.1016\/j.ejpb.2019.05.001_b0630","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.12766","article-title":"British Association of Dermatologists\u2019 guidelines for the management of squamous cell carcinoma in situ (Bowen\u2019s disease) 2014","volume":"170","author":"Morton","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0635","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Nikolaou","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0640","series-title":"Skin cancer a practical guide to management","author":"Colver","year":"2002"},{"key":"10.1016\/j.ejpb.2019.05.001_b0645","unstructured":"National Institute for Health and Care Excellence. (2015) Melanoma: assessment and management (NICE Quality Standard No. 39), (2015). https:\/\/www.nice.org.uk\/guidance\/ng14 (accessed December 31, 2017)."},{"issue":"Suppl","key":"10.1016\/j.ejpb.2019.05.001_b0650","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.0366-077X.2003.05626.x","article-title":"The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview","volume":"149","author":"Stockfleth","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0655","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer."},{"issue":"5","key":"10.1016\/j.ejpb.2019.05.001_b0660","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2019.05.001_b0665","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/med.20251","article-title":"photodynamictherapy based on 5-aminolevulinic acid and its use as an antimicrobial agent","volume":"29","author":"Harris","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejpb.2019.05.001_b0670","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2007.09.009","article-title":"Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: Application to photodynamic tumour targeting","volume":"89","author":"Donnelly","year":"2007","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0675","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2005.04.004","article-title":"Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum","volume":"298","author":"Singh","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0680","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijpharm.2008.05.034","article-title":"Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil","volume":"361","author":"Venuganti","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0685","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2016.07.043","article-title":"Mechanisms of imiquimod skin penetration","volume":"511","author":"Telo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0690","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.cgd.6b00552","article-title":"Improving the membrane permeability of 5-fluorouracil via cocrystallization","volume":"16","author":"Dai","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2019.05.001_b0695","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/B978-0-7020-6056-4.00055-1","article-title":"54 \u2013 nonsurgical management of non-melanoma skin cancer","author":"Coyle","year":"2017","journal-title":"Maxillofac. Surg."},{"key":"10.1016\/j.ejpb.2019.05.001_b0700","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2011.03.015","article-title":"Laser-assisted topical drug delivery by using a low-fluence fractional laser: Imiquimod and macromolecules","volume":"153","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0705","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2008.05.002","article-title":"Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: Potential for enhanced topical photodynamic therapy","volume":"129","author":"Donnelly","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0710","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s11095-010-0227-2","article-title":"Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema","volume":"27","author":"Mikolajewska","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0715","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1751-1097.2008.00417.x","article-title":"Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer","volume":"85","author":"Donnelly","year":"2009","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0720","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s11837-016-1841-1","article-title":"Use of drawing lithography-fabricated polyglycolic acid microneedles for transdermal delivery of itraconazole to a human basal cell carcinoma model regenerated on mice","volume":"68","author":"Zhang","year":"2016","journal-title":"Jom"},{"key":"10.1016\/j.ejpb.2019.05.001_b0725","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.apsb.2013.12.013","article-title":"The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil","volume":"4","author":"Naguib","year":"2014","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejpb.2019.05.001_b0730","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2016.08.015","article-title":"5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors","volume":"239","author":"Jain","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b0735","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1039\/C4PY01394H","article-title":"Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization","volume":"6","author":"Hu","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ejpb.2019.05.001_b0740","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/21645515.2016.1223000","article-title":"Local delivery of checkpoints antibodies","volume":"13","author":"Wang","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ejpb.2019.05.001_b0745","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1021\/acsnano.5b05043","article-title":"Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy","volume":"10","author":"Chen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2019.05.001_b0750","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2133.2012.11153.x","article-title":"Effective photodynamic therapy of actinic keratoses and Bowen\u2019s disease using microneedle perforation","volume":"168","author":"Kolde","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0755","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","article-title":"Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Letters"},{"key":"10.1016\/j.ejpb.2019.05.001_b0760","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/acsnano.6b04989","article-title":"Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors","volume":"10","author":"Ye","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2019.05.001_b0765","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/acsbiomaterials.6b00414","article-title":"In vivo expansion of melanoma-specific t cells using microneedle arrays coated with immune-polyelectrolyte multilayers","volume":"3","author":"Zeng","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejpb.2019.05.001_b0770","first-page":"347","article-title":"Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model","volume":"10","author":"Wang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2019.05.001_b0775","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjd.16406","article-title":"Bristol Cup Posters: P069 Enhancement in imiquimod permeation through microneedle skin pretreatment","volume":"179","author":"Sabri","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0780","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1021\/acsami.7b18293","article-title":"Au nanocage-strengthened dissolving microneedles for chemo-photothermal combined therapy of superficial skin tumors","volume":"10","author":"Dong","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2019.05.001_b0785","first-page":"1","article-title":"Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles","volume":"8","author":"Pan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2019.05.001_b0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.xphs.2018.05.017","article-title":"Intradermal delivery of a near-infrared photosensitizer using dissolving microneedle arrays","volume":"107","author":"Hamdan","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0795","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2018.10.043","article-title":"Coated microneedles mediated intradermal delivery of octaarginine \/ BRAF siRNA nanocomplexes for anti-melanoma treatment","volume":"553","author":"Ruan","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0800","first-page":"1","article-title":"Near-infrared responsive PEGylated gold nanorod and doxorubicin loaded dissolvable hyaluronic acid microneedles for human epidermoid cancer therapy","volume":"1800008","author":"Hao","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejpb.2019.05.001_b0805","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1021\/acsnano.8b03007","article-title":"Microneedle-assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma","volume":"12","author":"Tham","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2019.05.001_b0810","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1039\/C8BM00005K","article-title":"Composite-dissolving microneedle patches for chemotherapy and photothermal therapy in superficial tumor treatment","volume":"6","author":"Pei","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0815","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s13346-015-0241-3","article-title":"Enhanced skin delivery of vismodegib by microneedle treatment","volume":"5","author":"Nguyen","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2710.2000.00254.x","article-title":"Therapeutic strategies for psoriasis","volume":"25","author":"Ashcroft","year":"2000","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejpb.2019.05.001_b0825","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes","volume":"86","author":"Grossman","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejpb.2019.05.001_b0830","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1365-2133.1997.19892070.x","article-title":"Genetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands","volume":"137","author":"Swanbeck","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0835","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.1972.03190340067019","article-title":"The genetics of psoriasis","volume":"219","author":"Farber","year":"1972","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.ejpb.2019.05.001_b0840","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0845","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0733-8635(18)30044-5","article-title":"Topical corticosteroids","volume":"13","author":"Katz","year":"1995","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejpb.2019.05.001_b0850","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0855","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1211\/jpp.60.1.0004","article-title":"Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate","volume":"60","author":"Vemulapalli","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0860","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2369-6","article-title":"Delivery of methotrexate and characterization of skin treated by fabricated PLGA microneedles and fractional ablative laser","volume":"35","author":"Nguyen","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b0865","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1067\/mjd.2003.10","article-title":"Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-\u03b1 monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris","volume":"48","author":"Gottlieb","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0870","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1067\/mjd.2000.105948","article-title":"Treatment with anti-tumor necrosis factor \u03b1 (TNF-\u03b1) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions","volume":"42","author":"Oh","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0875","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.actbio.2015.05.036","article-title":"Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays","volume":"24","author":"Korkmaz","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2019.05.001_b0880","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0022-202X.2005.23809.x","article-title":"Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors","volume":"125","author":"Arbiser","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0885","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0890","first-page":"1","article-title":"Localized delivery of a lipophilic proteasome inhibitor into human skin for treatment of psoriasis","volume":"2330","author":"Gujjar","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2019.05.001_b0895","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejpb.2018.02.014","article-title":"Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles","volume":"127","author":"Jeong","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0900","unstructured":"Microneedle Patch for Psoriatic Plaques - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02955576 (accessed May 28, 2017)."},{"key":"10.1016\/j.ejpb.2019.05.001_b0905","first-page":"5","article-title":"A hyaluronic acid-based microneedle patch to treat psoriatic plaques: A pilot open trial","volume":"1","author":"Lee","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0910","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1085-5629(98)80026-6","article-title":"Quality of life assessments in dermatology","volume":"17","author":"Andrew","year":"1998","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.ejpb.2019.05.001_b0915","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.327.7421.942","article-title":"Topical corticosteroids in atopic dermatitis","volume":"327","author":"Atherton","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejpb.2019.05.001_b0920","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CCID.S6496","article-title":"Update on the management of chronic eczema: new approaches and emerging treatment options","volume":"3","author":"Walling","year":"2010","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0925","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.drudis.2016.02.011","article-title":"Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis","volume":"21","author":"Karuppagounder","year":"2016","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.ejpb.2019.05.001_b0930","article-title":"Mixture of polyphenols and anthocyanins from vaccinium uliginosum L. Alleviates DNCB-induced atopic dermatitis in NC\/Nga mice, Evidence-Based Complement","volume":"2012","author":"Kim","year":"2012","journal-title":"Altern. Med."},{"key":"10.1016\/j.ejpb.2019.05.001_b0935","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cyto.2015.05.016","article-title":"Tannic acid modulates NF\u03baB signaling pathway and skin inflammation in NC\/Nga mice through PPAR\u03b3 expression","volume":"76","author":"Karuppagounder","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2019.05.001_b0940","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/jid.2009.401","article-title":"Tannic acid and quercetin display a therapeutic effect in atopic dermatitis via suppression of angiogenesis and TARC expression in Nc\/Nga mice","volume":"130","author":"Jung","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0945","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lfs.2013.07.027","article-title":"The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC\/Nga mice","volume":"93","author":"Kim","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2019.05.001_b0950","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.intimp.2014.10.014","article-title":"Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice","volume":"23","author":"Karuppagounder","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0955","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijpharm.2014.06.010","article-title":"Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles","volume":"472","author":"Paleco","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.05.001_b0960","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/exd.12293","article-title":"The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients","volume":"23","author":"van Smeden","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0965","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care","volume":"19","author":"Vincent","year":"2008","journal-title":"Can J Infect Dis Med Microbiol."},{"key":"10.1016\/j.ejpb.2019.05.001_b0970","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/QCO.0000000000000252","article-title":"Fungal skin and soft tissue infections","volume":"29","author":"Gu\u00e9gan","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejpb.2019.05.001_b0975","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/dkq302","article-title":"Complicated skin and soft tissue infection","volume":"65","author":"Dryden","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2019.05.001_b0980","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijantimicag.2016.04.023","article-title":"Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe","volume":"48","author":"Nathwani","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejpb.2019.05.001_b0985","series-title":"Superficial Bacterial Skin Infections and Cellulitis","author":"Lawrence","year":"2012"},{"key":"10.1016\/j.ejpb.2019.05.001_b0990","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/adem.200980012","article-title":"Two photon polymerization-micromolding of polyethylene glycol-gentamicin sulfate microneedles","volume":"12","author":"Gittard","year":"2010","journal-title":"Adv. Eng. Mater."},{"key":"10.1016\/j.ejpb.2019.05.001_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.07.032","article-title":"Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis","author":"Gonz\u00e1lez-v\u00e1zquez","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.05.001_b1000","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/23744235.2015.1109136","article-title":"No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis patients with sepsis","volume":"48","author":"Cobussen","year":"2015","journal-title":"Infect. Dis. (Auckl)"},{"key":"10.1016\/j.ejpb.2019.05.001_b1005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema : an updated Cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1534734607302232","article-title":"A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery","volume":"7","author":"Bhattacharyya","year":"2008","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"10.1016\/j.ejpb.2019.05.001_b1015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-475X.2006.00179.x","article-title":"Zinc in wound healing: Theoretical, experimental, and clinical aspects","volume":"15","author":"Lansdown","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.ejpb.2019.05.001_b1020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1365-2672.2009.04303.x","article-title":"Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7","volume":"107","author":"Liu","year":"2009","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11837-011-0093-3","article-title":"Deposition of antimicrobial coatings on microstereolithography-fabricated microneedles","volume":"63","author":"Gittard","year":"2011","journal-title":"J. Miner. Met. Mater. Soc."},{"key":"10.1016\/j.ejpb.2019.05.001_b1030","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/4\/1\/011002","article-title":"Indirect rapid prototyping of antibacterial acid anhydride copolymer microneedles","volume":"4","author":"Boehm","year":"2012","journal-title":"Biofabrication."},{"key":"10.1016\/j.ejpb.2019.05.001_b1035","doi-asserted-by":"crossref","DOI":"10.1116\/1.4941448","article-title":"Inkjet deposition of itraconazole onto poly(glycolic acid) microneedle arrays","volume":"11","author":"Boehm","year":"2016","journal-title":"Biointerphases"},{"key":"10.1016\/j.ejpb.2019.05.001_b1040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.carbpol.2017.02.044","article-title":"In-situ deposition of Cu2O micro-needles for biologically active textiles and their release properties","volume":"165","author":"Emam","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2019.05.001_b1045","unstructured":"W. Lee, William, Q. Zhao, Y. Rao, Z. Shen, Disposable self-powered drug delivery device, WO2010062908, 2009. https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2010062908 (accessed January 2, 2018)."},{"key":"10.1016\/j.ejpb.2019.05.001_b1050","unstructured":"Kim Kabseog, Lee Jeong-Bong, Tapered hollow metallic microneedle array assembly and method of making and using the same, 7627938-B2, 2009. https:\/\/www.lens.org\/lens\/patent\/US_7627938_B2\/fulltext (accessed January 2, 2018)."},{"key":"10.1016\/j.ejpb.2019.05.001_b1055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/pharmaceutics7040397","article-title":"Methylene blue-loaded dissolving microneedles: Potential use in photodynamic antimicrobial chemotherapy of infected wounds","volume":"7","author":"Caffarel-Salvador","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2019.05.001_b1060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.msec.2014.06.021","article-title":"Wound healing potential of antibacterial microneedles loaded with green tea extracts","volume":"42","author":"Park","year":"2014","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.ejpb.2019.05.001_b1065","doi-asserted-by":"crossref","DOI":"10.1116\/1.4913378","article-title":"Polyglycolic acid microneedles modified with inkjet-deposited antifungal coatings","volume":"10","author":"Boehm","year":"2015","journal-title":"Biointerphases"},{"key":"10.1016\/j.ejpb.2019.05.001_b1070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11837-013-0574-7","article-title":"Inkjet printing of amphotericin B onto biodegradable microneedles using piezoelectric inkjet printing","volume":"65","author":"Boehm","year":"2013","journal-title":"Jom"},{"key":"10.1016\/j.ejpb.2019.05.001_b1075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.18063\/IJB.2017.02.004","article-title":"Printing amphotericin B on microneedles using matrix- assisted pulsed laser evaporation","volume":"3","author":"Sachan","year":"2017","journal-title":"Int. J. Bioprinting"},{"key":"10.1016\/j.ejpb.2019.05.001_b1080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mattod.2014.04.027","article-title":"Inkjet printing for pharmaceutical applications","volume":"17","author":"Boehm","year":"2014","journal-title":"Mater. Today"},{"key":"10.1016\/j.ejpb.2019.05.001_b1085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1039\/C8CC06035E","article-title":"Self-sterilizing antibacterial silver-loaded microneedles","volume":"55","author":"Garcia","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejpb.2019.05.001_b1090","first-page":"1","article-title":"Situ generation of zinc oxide nanobushes on microneedles as antibacterial coating","author":"Chew","year":"2018","journal-title":"SLAS Technol. Transl. Life Sci. Innov."},{"key":"10.1016\/j.ejpb.2019.05.001_b1095","doi-asserted-by":"crossref","first-page":"1800035","DOI":"10.1002\/adtp.201800035","article-title":"ROS-responsive microneedle patch for acne vulgaris treatment","volume":"1","author":"Zhang","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejpb.2019.05.001_b1100","doi-asserted-by":"crossref","unstructured":"M.D. Lynch, J. Cliffe, R. Morris-jones, Management of cutaneous viral warts, 3339 (2014) 1\u20136. http:\/\/doi.org\/10.1136\/bmj.g3339.","DOI":"10.1136\/bmj.g3339"},{"key":"10.1016\/j.ejpb.2019.05.001_b1105","series-title":"Skin disease diagnosis and treatment","author":"Habif","year":"2005"},{"key":"10.1016\/j.ejpb.2019.05.001_b1110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.1963.01590150022004","article-title":"Natural history of warts. A two-year study","volume":"87","author":"Massing","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1115","article-title":"Topical treatments for cutaneous warts (Review)","author":"Cs","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejpb.2019.05.001_b1120","doi-asserted-by":"crossref","unstructured":"K.S. Thomas, M.R. Keogh-Brown, J.R. Chalmers, R.J. Fordham, R.C. Holland, S.J. Armstrong, M.O. Bachmann, A.H. Howe, S. Rodgers, A.J. Avery, I. Harvey, H.C. Williams, Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model, Health Technol. Assess. 10 (2006) iii, ix\u201387. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16849001 (accessed December 27, 2017).","DOI":"10.3310\/hta10250"},{"key":"10.1016\/j.ejpb.2019.05.001_b1125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1346-8138.2009.00711.x","article-title":"Deep plantaris ulceration secondary to the topical treatment of wart with glutaraldehyde","volume":"36","author":"Fujisawa","year":"2009","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.ejpb.2019.05.001_b1130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjd.13310","article-title":"British Association of Dermatologists' guidelines for the management of cutaneous warts 2014","volume":"171","author":"Sterling","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(83)70112-X","article-title":"Bleomycin in the treatment of recalcitrant warts","volume":"9","author":"Shumer","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D362G0G3MJ","article-title":"Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common warts: a randomized clinical trial","volume":"13","author":"Adalatkhah","year":"2007","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.ejpb.2019.05.001_b1145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0378-6323.48428","article-title":"Intralesional bleomycin in the treatment of cutaneous warts: A randomized clinical trial comparing it with cryotherapy","volume":"75","author":"Dhar","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.139.3.337","article-title":"Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris","volume":"139","author":"Abess","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2006.07474.x","article-title":"Bleomycin and the skin","volume":"155","author":"Yamamoto","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2019.05.001_b1160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/DSS.0000000000000738","article-title":"Successful treatment of recalcitrant plantar warts with bleomycin and microneedling","volume":"42","author":"Konicke","year":"2016","journal-title":"Am. Soc. Dermatologic Surg."},{"key":"10.1016\/j.ejpb.2019.05.001_b1165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-016-2042-x","article-title":"Bleomycin-coated microneedles for treatment of warts","volume":"34","author":"Lee","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b1170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13346-017-0458-4","article-title":"Efficacy of a bleomycin microneedle patch for the treatment of warts","volume":"8","author":"Ryu","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2019.05.001_b1175","unstructured":"Global Transdermal Drug Delivery Market Worth USD 95.57 Billion by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Vendors: 3M Company, 4P Therapeutics, Biogel Technology - Research and Markets, (2016). https:\/\/www.businesswire.com\/news\/home\/20161111005701\/en\/Global-Transdermal-Drug-Delivery-Market-Worth-USD (accessed September 20, 2001)."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:34:37Z","timestamp":1760546077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119300694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":235,"alternative-id":["S0939641119300694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.05.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the applications of microneedles in dermatology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}